Drug Department asking for documents to be notarizerd. What does it means? How documents should be notarized?
Notary means a person authorized to perform certain legal formalities, especially to draw up or certify contracts, deeds, and other documents for... Read More
CDSCO rejects Cipla’s application for marketing US-based MannKind Corporation’s inhaled insulin, branded Afrezza; Local climical trial is compulsory
An expert panel of the Central Drugs Standard Control Organisation (CDSCO) has insisted that a local clinical trial should be compulsorily conducted... Read More
DCGI making it mandatory to include warning in the package insert and promotional literature SGLT2 inhibitor drugs
SGLT2 inhibitors SGLT2 inhibitors, medicines that lower blood sugar by causing kidneys to remove sugar from the body through urine, include drugs... Read More
In India, insight on the ban of OTC sale of skin medications containing hydroquinone from April 1
Come April and pharmacies in the country have to stop selling topical medications containing hydroquinone, a bleaching agent for reducing skin pigmentation,... Read More
In India, Prices of 390 cancer drugs slashed by upto 87%
The maximum retail price of 390 non-scheduled cancer medicines have been reduced by up to 87 per cent, which would result in... Read More
Key Understanding on Price monitoring and research units (PMRUs) intiative in India
PMRUs intitative is adopted by The National Pharmaceutical Pricing Authority (NPPA). Under the initiative NPPA facilitates price monitoring and research units (PMRUs)... Read More
Case Study – Quick Look up at DCGI approval of Lundbeck’s Brintellix
Posted on15 Oct 2018
TagsBrintellix, CDSCO, codevelopment deal in pharma, comarketing deal in pharma, copromotion deal in pharma, DCGI, Lundbeck, vortioxetine
Comments0
Lundbeck India Private Limited (LIPL) announces the launch of Brintellix (vortioxetine) in India for the treatment of patients suffering from major depressive... Read More
Indian health ministry banned 329 controversial fixed dose combination with immediate effect
The ministry of health and family welfare has prohibited the manufacture for sale, sale or distribution for human use of 329 fixed... Read More
AstraZeneca’s Lynpraza got DCGI (India) marketing approval
AstraZeneca Pharma India has received Import & Market permission for olaparib (Lynparza )100 mg and 150 mg tablets in India by the... Read More
New Drug Approved in India tilldate 2018
List of New drug approved in India in 2018 Tilldate .No Name of drug Indication Date of issue 1 Tenofovir Alafenamide Hemifumarate... Read More